Reviews in Cardiovascular Medicine (Dec 2020)
Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence
- Jasjit S. Suri,
- Anudeep Puvvula,
- Misha Majhail,
- Mainak Biswas,
- Ankush D. Jamthikar,
- Luca Saba,
- Gavino Faa,
- Inder M. Singh,
- Ronald Oberleitner,
- Monika Turk,
- Saurabh Srivastava,
- Paramjit S. Chadha,
- Harman S. Suri,
- Amer M. Johri,
- Vijay Nambi,
- J Miguel Sanches,
- Narendra N. Khanna,
- Klaudija Viskovic,
- Sophie Mavrogeni,
- John R. Laird,
- Arindam Bit,
- Gyan Pareek,
- Martin Miner,
- Antonella Balestrieri,
- Petros P. Sfikakis,
- George Tsoulfas,
- Athanasios Protogerou,
- Durga Prasanna Misra,
- Vikas Agarwal,
- George D. Kitas,
- Raghu Kolluri,
- Jagjit Teji,
- Michele Porcu,
- Mustafa Al-Maini,
- Ann Agbakoba,
- Meyypan Sockalingam,
- Ajit Sexena,
- Andrew Nicolaides,
- Aditya Sharma,
- Vijay Rathore,
- Vijay Viswanathan,
- Subbaram Naidu,
- Deepak L. Bhatt
Affiliations
- Jasjit S. Suri
- Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, 95747, CA, USA
- Anudeep Puvvula
- Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, 95747, CA, USA
- Misha Majhail
- Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, 95747, CA, USA
- Mainak Biswas
- JIS University, Kolkata, 700001, West Bengal, India
- Ankush D. Jamthikar
- Department of ECE, Visvesvaraya National Institute of Technology, Nagpur, 440010, MH, India
- Luca Saba
- Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09100, Cagliari, Italy
- Gavino Faa
- Department of Pathology, AOU of Cagliari, 09100, Italy
- Inder M. Singh
- Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, 95747, CA, USA
- Ronald Oberleitner
- Behavior Imaging, Boise, 83701, ID, USA
- Monika Turk
- The Hanse-Wissenschaftskolleg Institute for Advanced Study, 27749, Delmenhorst, Germany
- Saurabh Srivastava
- School of Computing Science & Engineering, Galgotias University, 201301, Gr. Noida, India
- Paramjit S. Chadha
- Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, 95747, CA, USA
- Harman S. Suri
- Brown University, Providence, 02912, RI, USA
- Amer M. Johri
- Department of Medicine, Division of Cardiology, Queen's University, Kingston, B0P 1R0, Ontario, Canada
- Vijay Nambi
- Department of Cardiology, Baylor College of Medicine, 77001, TX, USA
- J Miguel Sanches
- Institute of Systems and Robotics, Instituto Superior Tecnico, 1000-001, Lisboa, Portugal
- Narendra N. Khanna
- Department of Cardiology, Indraprastha APOLLO Hospitals, 110001, New Delhi, India
- Klaudija Viskovic
- University Hospital for Infectious Diseases, 10000, Zagreb, Crotia
- Sophie Mavrogeni
- Cardiology Clinic, Onassis Cardiac Surgery Center, 104 31, Athens, Greece
- John R. Laird
- Heart and Vascular Institute, Adventist Health St. Helena, St Helena, 94574, CA, USA
- Arindam Bit
- Department of Biomedical Engineering, NIT, Raipur, 783334, CG, India
- Gyan Pareek
- Minimally Invasive Urology Institute, Brown University, Providence, 02901, Rhode Island, USA
- Martin Miner
- Men's Health Center, Miriam Hospital Providence, 02901, Rhode Island, USA
- Antonella Balestrieri
- Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09100, Cagliari, Italy
- Petros P. Sfikakis
- Rheumatology Unit, National Kapodistrian University of Athens, 104 31, Greece
- George Tsoulfas
- Aristoteleion University of Thessaloniki, 544 53, Thessaloniki, Greece
- Athanasios Protogerou
- National & Kapodistrian University of Athens, 104 31, Greece
- Durga Prasanna Misra
- Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226001, UP, India
- Vikas Agarwal
- Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226001, UP, India
- George D. Kitas
- Academic Affairs, Dudley Group NHS Foundation Trust, DY1, Dudley, UK
- Raghu Kolluri
- OhioHealth Heart and Vascular, 45874, Ohio, USA
- Jagjit Teji
- Ann and Robert H. Lurie Children's Hospital of Chicago, 60601, Chicago, USA
- Michele Porcu
- Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09100, Cagliari, Italy
- Mustafa Al-Maini
- Allergy, Clinical Immunology and Rheumatology Institute, M3H 6A7, Toronto, Canada
- Ann Agbakoba
- University of Lagos, 100001, Lagos, Nigeria
- Meyypan Sockalingam
- MV Center of Diabetes, 600001, Chennai, India
- Ajit Sexena
- Department of Cardiology, Indraprastha APOLLO Hospitals, 110001, New Delhi, India
- Andrew Nicolaides
- Vascular Screening and Diagnostic Centre and University of Nicosia Medical School, 999058, Cyprus
- Aditya Sharma
- Division of Cardiovascular Medicine, University of Virginia, Charlottesville, 22901, VA, USA
- Vijay Rathore
- Nephrology Department, Kaiser Permanente, Sacramento, 94203, CA, USA
- Vijay Viswanathan
- MV Hospital for Diabetes and Professor M Viswanathan Diabetes Research Centre, 600001, Chennai, India
- Subbaram Naidu
- Electrical Engineering Department, University of Minnesota, Duluth, 55801, MN, USA 37
- Deepak L. Bhatt
- Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, 02108, MA, USA
- DOI
- https://doi.org/10.31083/j.rcm.2020.04.236
- Journal volume & issue
-
Vol. 21,
no. 4
pp. 541 – 560
Abstract
Artificial Intelligence (AI), in general, refers to the machines (or computers) that mimic "cognitive" functions that we associate with our mind, such as "learning" and "solving problem". New biomarkers derived from medical imaging are being discovered and are then fused with non-imaging biomarkers (such as office, laboratory, physiological, genetic, epidemiological, and clinical-based biomarkers) in a big data framework, to develop AI systems. These systems can support risk prediction and monitoring. This perspective narrative shows the powerful methods of AI for tracking cardiovascular risks. We conclude that AI could potentially become an integral part of the COVID-19 disease management system. Countries, large and small, should join hands with the WHO in building biobanks for scientists around the world to build AIbased platforms for tracking the cardiovascular risk assessment during COVID-19 times and long-term follow-up of the survivors.
Keywords
